Ying Fu, MD; Junwei Hao, MD, PhD; Ningnannan Zhang, MD, PhD; et al.
free access
JAMA Neurol. 2014;71(9):1092-1101. doi:10.1001/jamaneurol.2014.1065
Fu and colleagues investigated whether oral administration of fingolimod is safe and effective in alleviating perihematomal edema and neurologic deficits in patients with intracerebral hemorrhage. Sheth and Rosand provided a related .
-
Editorial
Targeting the Immune System in Intracerebral Hemorrhage
Kevin N. Sheth, MD; Jonathan Rosand, MD, MSc
JAMA Neurol
Kathryn C. Fitzgerald, MSc; Éilis J. O鈥橰eilly, ScD; Guido J. Falcone, MD; et al.
free access
JAMA Neurol. 2014;71(9):1102-1110. doi:10.1001/jamaneurol.2014.1214
Fitzgerald and colleagues examined the association between 蠅-6 and 蠅-3 polyunsaturated fatty acid (PUFA) consumption and the risk for amyotrophic lateral sclerosis (ALS). Swash provided a related .
Jewell B. Thomas, BA; Matthew R. Brier, BS; Randall J. Bateman, MD; et al.
free access
has multimedia
JAMA Neurol. 2014;71(9):1111-1122. doi:10.1001/jamaneurol.2014.1654
-
Video:
Intranetwork and Internetwork Default Mode Functional Connectivity
Margaux F. Keller, BA; Luigi Ferrucci, MD, PhD; Andrew B. Singleton, PhD; et al.
free access
JAMA Neurol. 2014;71(9):1123-1134. doi:10.1001/jamaneurol.2014.1184
Keller and coauthors estimate the relative importance of genetic factors in a complex disease such as amyotrophic lateral sclerosis by accurately quantifying heritability using genome-wide data derived from genome-wide association studies.
Adriano Chiò, MD; Andrea Calvo, MD, PhD; Giacomo Bovio, MD; et al.
free access
JAMA Neurol. 2014;71(9):1134-1142. doi:10.1001/jamaneurol.2014.1129
Chi貌 and colleagues correlate several hematological markers evaluated at diagnosis with ALS outcome in a population-based series of patients (discovery cohort) and replicate the findings in an independent validation cohort from an ALS tertiary center.
Brian C. Callaghan, MD; Kevin A. Kerber, MD; Lynda L. Lisabeth, PhD; et al.
free access
JAMA Neurol. 2014;71(9):1143-1149. doi:10.1001/jamaneurol.2014.1279
Callaghan and coauthors determine how often neurologists and diagnostic tests influence the diagnosis and treatment of patients with distal symmetric polyneuropathy.
Elaine R. Peskind, MD; Ge Li, MD, PhD; Jane B. Shofer, MS; et al.
free access
JAMA Neurol. 2014;71(9):1150-1154. doi:10.1001/jamaneurol.2014.1428
Peskind et al identify potentially modifiable risk factors associated with increased markers of brain oxidative stress.
Kori Sauser, MD, MSc; Deborah A. Levine, MD, MPH; Adrienne V. Nickles, MPH; et al.
free access
JAMA Neurol. 2014;71(9):1155-1161. doi:10.1001/jamaneurol.2014.1528
Sauser et al examine the contributions of door-to-imaging time and imaging-to-needle time to delays in delivery of tissue plasminogen activator to patients with acute ischemic stroke.
Eleanna Kara, MD, MSc; Aoife P. Kiely, PhD; Christos Proukakis, MD, PhD; et al.
free access
JAMA Neurol. 2014;71(9):1162-1171. doi:10.1001/jamaneurol.2014.994
Kara and colleagues report a novel family carrying a heterozygous 6.4 Mb duplication of the alpha-synuclein locus with an atypical clinical presentation strongly reminiscent of frontotemporal dementia and late-onset pallidopyramidal syndromes and study phenotype-genotype correlations in 伪-synuclein locus duplications.